Farid Marjan 4
4 · Kala Pharmaceuticals, Inc. · Filed Nov 1, 2022
Insider Transaction Report
Form 4
Farid Marjan
Director
Transactions
- Award
Stock Option (right to buy)
2022-10-31+1,600→ 1,600 totalExercise: $6.35Exp: 2032-10-30→ Common Stock (1,600 underlying)
Footnotes (1)
- [F1]This option was granted on October 31, 2022 and vests with respect to 1/3rd of the shares underlying the option on October 31, 2023 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 31, 2025.